Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-01-23

Clinical Trial Update: Fermented Wheat Germ Extract in Women With Ovarian Cancer [EARLY_Phase 1]

View source ↗

Summary

An early-phase trial evaluating Fermented Wheat Germ Extract in women with ovarian cancer; the study was terminated and results were posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fermented Wheat Germ Extract (fermented wheat germ extract)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Ovarian Cancer | EARLY_Phase 1 | Status: TERMINATED | Results posted: 2019-01-23